Contamination of the active substance ranitidine with N-nitrosodimethylamine (NDMA) was detected, causing the batches to be deemed non-compliant with quality requirements and potentially hazardous to patients’ health or life. Potential effects: carcinogenic action, organ damage, general poisoning.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use tablets from the listed batches; check the batch number on the packaging and, if you have the product, return it to a pharmacy or consult a doctor.
Withdrawal from the market throughout the country of the listed batches of the medicinal product Raniberl Max and granting the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related